Tristan ensures the development of global strategic partnerships and customer relationships to meet Aryballe’s long term vision for the potential of digital olfaction. Prior to founding Aryballe in 2014, Tristan was the founder and CEO of PX’Therapeutics which specialized in the development of therapeutic proteins. PX’Therapeutics was sold to Aguettan Biotech in 2012. Tristan holds a PhD in Cell Biology from Grenoble University (France).